A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia.
BACKGROUND
Mass drug administration (MDA) is a strategy widely used in the control of human parasitic diseases but has been rarely attempted with malaria, the most common and dangerous parasitic disease in humans. MDA is an intervention strategy that involves simultaneously dispensing treatment to an entire population in a given geographic area. With some areas in sub-Saharan Africa documenting a decline in malaria transmission, the feasibility of MDA to further reduce malaria transmission is being considered. Understanding community perceptions of such an activity is vitally important for the design of the study and gaining the support of participants in order to maximize compliance and adherence.


METHODS
A qualitative study to assess factors likely to influence community acceptance of MDA in the seasonal and low malaria transmission setting of The Gambia was conducted. Using in-depth interviews, the perceptions, knowledge and attitudes of medical personnel and community members who have undergone MDA trials in The Gambia were investigated.


RESULTS
Several major themes emerged, namely: 1) the importance of timing of rounds of MDA doses for maximum participation; 2) the need to educate the target population with accurate information on the procedures, drug regimen, and possible side effects to enhance adherence; 3) the need for continuous sensitization meetings to maintain and increase uptake of MDA; and, 4) the importance for defining roles in the delivery and assessment of MDA, including existing healthcare structures.


CONCLUSIONS
To increase the likelihood of participation in MDA trials in this setting, activities should be undertaken just before and during the rainy season when community members are less mobile. Importantly, fears regarding blood sampling and side effects of the drug regimen need to be addressed prior to the start of the trial and repeated throughout the study period. Accurate and frequent communication is essential, and village leaders should consistently be included in sensitization meetings to enhance community participation. Additionally, village healthcare workers should be included in training and implementation, with supervision by a fieldworker permanently posted in every few villages during the trial. Future collaboration with Senegal may prove important for enhanced elimination efforts in The Gambia.
Department of Global Health Sciences, University of California San Francisco, 50 Beale Street Ste, 1200, San Francisco, CA 94105, USA. njdial@gmail.com.
Natalie J
NJ
Dial
Serign J
SJ
Ceesay
Roly D
RD
Gosling
Umberto
U
D'Alessandro
Kimberly A
KA
Baltzell
D000962:Antimalarials / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003256:Community Participation; D005714:Gambia; D007722:Health Knowledge, Attitudes, Practice; D008288:Malaria / Q000188:drug therapy*; D036301:Qualitative Research; D012424:Rural Population
D000962:Antimalarials